Erin Gallagher has a diverse work experience in the field of chemistry. Erin started their career as an intern at Bayer MaterialScience, where they mixed and applied different types of coatings and analyzed their strength and stability. Later, they worked as a chemistry tutor at the University of Dayton, where they provided one-on-one tutoring to students, focusing on reteaching difficult concepts and problem-solving strategies. Erin then pursued their education at the University of Michigan, where they served as a graduate student from 2013 to 2018. Currently, Erin is working at Sapience Therapeutics, Inc. as a Senior Scientist.
Erin Gallagher holds a Doctor of Philosophy (Ph.D.) degree in Medicinal and Pharmaceutical Chemistry, which they obtained from the University of Michigan from 2013 to 2018. Prior to that, they completed their undergraduate studies at the University of Dayton, where they earned a Bachelor of Science (BS) degree in Biochemistry from 2009 to 2013.
This person is not in any offices
Sapience Therapeutics, Inc.
1 followers
Sapience Therapeutics is a preclinical-stage biotechnology company focused on advancing novel therapeutics for major unmet medical needs, particularly high mortality cancers. Our drug development program involves translating science into novel therapies, and our initial goal is to develop a first-in-class treatment for glioblastoma multiforme(GBM), which is the most severe and deadly form of brain cancer.The company was founded in 2015 by Barry Kappel and is based in Scarsdale, New York, United States.